Works matching IS 11732563 AND DT 2020 AND VI 40 AND IP 11

Results: 10

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1063, doi. 10.1007/s40261-020-00970-y

By:

Narasimhalu, Kaavya;
Ang, Yoong Kwei;
Tan, Doreen Su Yin;
De Silva, Deidre Anne;
Tan, Kelvin Bryan

Publication type:

Article

Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1071, doi. 10.1007/s40261-020-00968-6

By:

Ebata-Kogure, Nozomi;
Murakami, Aya;
Nozawa, Kazutaka;
Fujii, Koichi;
Lin, Yingsong;
Ushida, Takahiro;
Kikuchi, Shogo

Publication type:

Article

Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report.

Published in:

2020

By:

Streicher, Caroline;
Engalenc, Xavier;
Gaudin, Marion;
Vignaud, Guillaume;
Daulange, Annick;
Abraham, Bruno

Publication type:

Letter

Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1053, doi. 10.1007/s40261-020-00967-7

By:

Frol, Senta;
Sernec, Lana Podnar;
Hudnik, Liam Korošec;
Šabovič, Mišo;
Oblak, Janja Pretnar

Publication type:

Article

Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naïve Patients with Cancer Pain.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1041, doi. 10.1007/s40261-020-00965-9

By:

Yamaguchi, Shigeki;
Uchida, Eiji;
Terahara, Takaaki;
Okawa, Koji;
Hashimoto, Fumitaka;
Tanaka, Yusuke

Publication type:

Article

New-Onset Vitiligo During Treatment with Secukinumab: Report of Two Cases and Review of the Literature.

Published in:

2020

By:

Nieto-Benito, Lula María;
Baniandrés-Rodríguez, Ofelia

Publication type:

Letter

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1001, doi. 10.1007/s40261-020-00962-y

By:

Bellesini, Marta;
Bianchin, Matteo;
Corradi, Chiara;
Donadini, Marco Paolo;
Raschi, Emanuel;
Squizzato, Alessandro

Publication type:

Article

Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1021, doi. 10.1007/s40261-020-00959-7

By:

Ziyadeh, Najat J.;
Geldhof, Anja;
Noël, Wim;
Otero-Lobato, Marijo;
Esslinger, Suzan;
Chakravarty, Soumya D.;
Wang, Yiting;
Seeger, John D.

Publication type:

Article

Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 1009, doi. 10.1007/s40261-020-00957-9

By:

Gorwood, Philip;
Benichou, Jacques;
Moore, Nicolas;
Wattez, Marine;
Secouard, Marie-Cécile;
Desobry, Xavier;
Picarel-Blanchot, Françoise;
de Bodinat, Christian

Publication type:

Article

Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 11, p. 991, doi. 10.1007/s40261-020-00949-9

By:

Li, Ning;
Chen, Ruimin;
Liu, Kewei

Publication type:

Article